The new technologies are intended to make life easier for people. In this sense, they are also key in matters of health and help to prevent and treat different diseases. This is the case of people with diabetes, who live with the need to regularly control the levels of glucose in the blood.
In this sense, traditional blood glucose monitoring devices are based on a small finger prick obtaining a small blood sample. However, for years, different groups of researchers have been working on a non-invasive alternative.
Now, the Canadian company 'Scanbo' has succeeded in developing a device that works by combining non-invasive diagnostic tools with machine learning.
In addition, it is also important to note that another totally independent group of researchers has recently found an alternative molecule that acts in a
similar way to insulin in the body. This discovery represents a relevant advance in the field of treatment for patients with diabetes.
New non-invasive glucose meter
This new non-invasive blood glucose meter developed by the company 'Scanbo', aims to improve the lives of people with diabetes. Specifically, the user should only place their hands on the device for 60 seconds, so that the system of it analyzes the necessary medical readings and intelligently calculates the blood glucose level.
One of the most important features of this new device is that it has different PPG, ECG and artificial intelligence sensors. These are elements that make this new product an interesting blood glucose meter, especially for patients with diabetes.
The key to this new non-invasive glucose meter is based on its ability to measure the user's vital signs. Thus, it monitors the heart rate (ECG) and on the other hand it has photoplethysmography (PPG), which is commonly used to measure the different variations in blood volume as a result of cardiac activity.
A revolutionary model for people with diabetes
It must be made clear that the device developed by the company 'Scanbo' really takes the raw data from both measurements. From there, it transfers said data to a convolutional network and a deep neural network.
Thus, using different algorithms, the user receives in a matter of minutes the precise result of the blood glucose levels that he presents at that moment. It is a practically real estimation, which allows the patient to control the glycaemia.
The effectiveness of this new non-invasive blood glucose meter has aroused the interest of large technology firms. However, everything indicates that 'Scanbo' will market this product under its own brand in the coming months.
However, the developers of this innovative glucose meter clarify that there is still an important process before this device can be sold on a regular basis as a product indicated for the control of blood glucose.
Once the device passes different controls and clinical trials, the Food and Drug Administration (FDA) must give the green light to start marketing it in the United States. Later, it could become a product sold all over the world.
